Monoclonal antibody against soluble transferrin receptor as well as preparation method and application thereof

By preparing and expressing rabbit-derived anti-soluble transferrin receptor monoclonal antibodies designed with specific amino acid sequences, the shortcomings of existing antibodies in affinity and cost are overcome, and high-specificity and high-sensitivity detection effects are achieved, making it suitable for a variety of detection technologies.

CN120647765AActive Publication Date: 2025-09-16HANGZHOU STAR BIOTECHNOLOGY CO LTD

Patent Information

Application Number
CN202510806754.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-06-17
Publication Date
2025-09-16
Estimated Expiration
2045-06-17

AI Technical Summary

Technical Problem

Existing mouse and rabbit anti-soluble transferrin receptor antibodies have limited affinity or high cost in biomedical research, diagnosis and treatment, making it difficult to meet the detection needs of high specificity and high sensitivity.

Method used

Rabbit-derived anti-soluble transferrin receptor monoclonal antibodies are prepared using a specific amino acid sequence design and expressed in Expi293F or CHO cell lines via a recombinant expression vector. Purified antibodies with high specificity and sensitivity are then used to detect soluble transferrin receptor in blood.

Benefits of technology

It achieves high specificity and high sensitivity detection of soluble transferrin receptor, and is suitable for techniques such as immunohistochemistry, indirect ELISA, antibody chip, flow cytometry and immunofluorescence, improving the accuracy and reliability of detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120647765A_ABST
    Figure CN120647765A_ABST
Patent Text Reader

Abstract

The invention discloses an anti-soluble transferrin receptor monoclonal antibody as well as a preparation method and application thereof, and belongs to the technical field of antibody detection. According to the antibody, an L101-F760 amino acid sequence of human TfR protein is used as an immunogen, specific screening of B cells, reverse RNA (Ribonucleic Acid) into cDNA (Complementary Deoxyribose Nucleic Acid) through RT-PCR (Reverse Transcription-Polymerase Chain Reaction), then homologous recombination is performed to construct heavy and light chain vectors, and finally multiple rounds of screening are performed to obtain the purified sTfR monoclonal antibody, so that the sTfR protein can be specifically recognized, and the antibody has the advantages of high specificity and high sensitivity and can be widely applied to the field of immunotherapy. The natural sTfR protein in human serum can be recognized. The kit is applied to the detection and screening fields of immunohistochemistry, immunofluorescence chemistry, western blot, co-immunoprecipitation, indirect ELISA, flow cytometry and the like, especially has low background and no interference of non-specific binding impure protein during immunohistochemistry detection, can obtain more accurate detection and evaluation results, avoids interference of false positive and false negative, and has high detection accuracy. The method has great application value in the aspects of basic scientific research and clinical pathology detection.
Need to check novelty before this filing date? Find Prior Art

Claims

1. An anti-soluble transferrin receptor monoclonal antibody or an antigen-binding fragment thereof, characterized in that: include: (i) a heavy chain variable region with an amino acid sequence as shown in SEQ ID NO. 2 and a light chain variable region with an amino acid sequence as shown in SEQ ID NO. 3; or (ii) a heavy chain variable region with an amino acid sequence as shown in SEQ ID NO. 4 and a light chain variable region with an amino acid sequence as shown in SEQ ID NO. 5; or (iii) the heavy chain variable region having an amino acid sequence as shown in SEQ ID NO.6, and the light chain variable region having an amino acid sequence as shown in SEQ ID NO.

7.

2. The anti-soluble transferrin receptor monoclonal antibody or antigen-binding fragment thereof according to claim 1, characterized in that The antibody comprises a heavy chain constant region whose amino acid sequence is shown in SEQ ID NO.8 and a light chain constant region whose amino acid sequence is shown in SEQ ID NO.

9.

3. The anti-soluble transferrin receptor monoclonal antibody or antigen-binding fragment thereof according to claim 1 or 2, characterized in that: The antigen-binding fragment is a Fab fragment, a Fab' fragment, a F(ab)'2 fragment, a single-chain Fv protein or a disulfide-stabilized Fv protein.

4. A nucleic acid, characterized in that The nucleic acid encodes the anti-soluble transferrin receptor or antigen-binding fragment thereof according to any one of claims 1 to 3, or the heavy chain variable region and / or light chain variable region thereof.

5. The nucleic acid according to claim 4, characterized in that The nucleotide sequence of the nucleic acid encoding the heavy chain variable region with the amino acid sequence shown in SEQ ID NO.2 is shown in SEQ ID NO.10; The nucleotide sequence of the nucleic acid encoding the light chain variable region with the amino acid sequence shown in SEQ ID NO.3 is shown in SEQ ID NO.11; The nucleotide sequence of the nucleic acid encoding the heavy chain variable region with the amino acid sequence shown in SEQ ID NO.4 is shown in SEQ ID NO.12; The nucleotide sequence of the nucleic acid encoding the light chain variable region with the amino acid sequence shown in SEQ ID NO.5 is shown in SEQ ID NO.13; The nucleotide sequence of the nucleic acid encoding the heavy chain variable region with the amino acid sequence shown in SEQ ID NO.6 is shown in SEQ ID NO.14; The nucleotide sequence of the nucleic acid encoding the light chain variable region with the amino acid sequence shown in SEQ ID NO.7 is shown in SEQ ID NO.

15.

6. A recombinant expression vector, characterized in that: The recombinant expression vector contains the nucleic acid according to claim 4 or 5.

7. A recombinant expression cell, characterized in that The recombinant expression cell comprises the recombinant expression vector according to claim 6, or the nucleic acid encoding the anti-soluble transferrin receptor monoclonal antibody or the antigen-binding fragment thereof according to claim 4 or 5.

8. Use of the nucleic acid encoding the anti-soluble transferrin receptor monoclonal antibody or the antigen-binding fragment thereof according to claim 4 or 5, or the recombinant expression vector according to claim 6, or the recombinant expression cell according to claim 7 in the preparation of the anti-soluble transferrin receptor monoclonal antibody or the antigen-binding fragment thereof.

9. A method for preparing an anti-soluble transferrin receptor monoclonal antibody or an antigen-binding fragment thereof, comprising: The recombinant expression vector of claim 6 is used to transfect cells to obtain recombinant expression cells, and the recombinant expression cells are cultured; or the recombinant expression cells of claim 7 are cultured; the supernatant is collected and purified to obtain an anti-soluble transferrin receptor monoclonal antibody or an antigen-binding fragment thereof.

10. Use of the anti-soluble transferrin receptor monoclonal antibody or antigen-binding fragment thereof according to any one of claims 1 to 3, or the nucleic acid encoding the anti-soluble transferrin receptor monoclonal antibody or antigen-binding fragment thereof according to claim 4 or 5, or the recombinant expression vector according to claim 6, or the recombinant expression cell according to claim 7 in detecting soluble transferrin receptor or preparing a product for detecting soluble transferrin receptor.

11. The use according to claim 10, characterized in that The detection includes any one or more of ELISA, immunoblotting, cell immunofluorescence and immunohistochemistry.

12. A kit for detecting soluble transferrin receptor, characterized in that: The kit comprises the anti-soluble transferrin receptor monoclonal antibody or antigen-binding fragment thereof according to any one of claims 1 to 3.

13. The kit for detecting soluble transferrin receptor according to claim 12, characterized in that: The kit comprises: an anti-soluble transferrin receptor monoclonal antibody or an antigen-binding fragment thereof having a heavy chain variable region with an amino acid sequence as shown in SEQ ID NO.6 and a light chain variable region with an amino acid sequence as shown in SEQ ID NO.7; and An anti-soluble transferrin receptor monoclonal antibody or an antigen-binding fragment thereof having a heavy chain variable region as shown in SEQ ID NO.2 and a light chain variable region as shown in SEQ ID NO.3; or an anti-soluble transferrin receptor monoclonal antibody or an antigen-binding fragment thereof having a heavy chain variable region as shown in SEQ ID NO.4 and a light chain variable region as shown in SEQ ID NO.5.

Citation Information

Patent Citations

  • Recombinant immunoglobin preparations

    US4816567A

  • Anti-transferrin antibody and application thereof

    CN109336973A

  • Anti-soluble transferrin receptor antibody and application thereof

    CN112409487A

Cited By

  • Detection kit based on beta-trace protein monoclonal antibody and application thereof

    CN122080219A